Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,003 recalls · newest first
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
CGMP Deviations: Products not manufactured under current good manufacturing practices.
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for…
CGMP Deviations
Failed dissolution specifications - results obtained were below spec average.
CGMP Deviations
CGMP Deviations
CGMP Deviations
Failed Impurities/Degradation Specifications
cGMP deviations: Batch was released prior to approval.
cGMP deviations: Batch was released prior to approval.
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
CGMP Deviations: Raw material recalled by repackager, due to discoloration.